Services and Capabilities
Evaluating candidate medications for central nervous system disorders with specialized services
We apply expertise in behavioral pharmacology to design in vivo models to evaluate therapeutic efficacy and side effect profiles of candidate medications. Through this process, our scientists help clients develop safe and effective medications to treat disorders of the central nervous system.
Using a personalized approach, we collaborate with internal and external investigators and work with clients to design and conduct behavioral studies consistent with their goals. Our team evaluates structure-activity relationship and therapeutic efficacy of novel compounds for drug development, with a specialty in substance abuse liability assessment.
Meet the Experts
View All Experts
Navigate to
Kimberly Michelle Jenkins
Kimberly Michelle Jenkins
Navigate to
Jeffrey Ambroso
Jeffrey Ambroso
Navigate to
Joëlla W. Adams
Joëlla W. Adams
Navigate to
Felicia Browne
Felicia Browne
Navigate to
Julie A. Marusich
Julie A. Marusich
Navigate to
Josephine A. Mauskopf
Josephine A. Mauskopf
Related Projects
Mapping the Kappa Opioid Receptor Using RTI's JDTic Compound
New insights enable structure-based discovery of new drugs
Read More about Mapping the Kappa Opioid Receptor Using RTI's JDTic Compound
